Wednesday, June 10, 2026

Intelligence · Patents

Patents expiring in 2031

Annual patent cliff calendar for 2031 — US pharmaceutical patents by expiration date.

Patents
902

Quick answer

902 indexed pharmaceutical patents have expiration dates in 2031. Browse by soonest expiry with links to assignee companies and related drugs.

  1. EP 2336066

    Spule mit darauf aufgewickelter beschichteter Folienbahn

    ACINO AG [DE] · Granted Wed Jun 22 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jun 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. US 7968545

    Compositions useful as inhibitors of voltage-gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 7968716

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. US 7968117

    Externally triggered microcapsules

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. US 7968298

    Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit CCR5-tropic HIV-1 infection and replication

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. US 7968115

    Liposomal curcumin for treatment of cancer

    The Board of Regents of the University of Texas System · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. US 7968559

    Methods of using 4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. US 7968080

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. US 7968749

    Process for preparing and drying solid rasagiline base

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. US 7968714

    Optical determination of glucose utilizing boronic acid adducts

    The Regents of the University of California · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. US 7968726

    Methods of preparing imidazole-based bicyclic compounds

    LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. US 7968664

    Nitric oxide-releasing diazeniumdiolated acrylonitrile-based polymers, and compositions, medical devices, and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. US 7968615

    Polymerizable monomer, polymerizable composition and dental material

    Kuraray Medical Inc. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. US 7968511

    Combination therapy with glatiramer acetate and mitoxantrone for the treatment of multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 28 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 23 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. CA 2785117

    SYSTEME THERAPEUTIQUE TRANSDERMIQUE SERVANT A ADMINISTRER DE LA RIVASTIGMINE OU SES DERIVES

    ACINO AG [DE] · Granted Thu Jun 30 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. US 7973038

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. US 7973162

    Modulators of muscarinic receptors

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. US 7972606

    T24 antigen for immunodiagnosis of Taenia solium cysticercosis

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. US 7972661

    Electrospraying method with conductivity control

    Regents of the University of Minnesota · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. US 7972601

    Method of promoting delivery of an antioxidant agent to a cell expression neuroligin

    The Regents of the University of California · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. US 7972793

    Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype

    SureGene LLC · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. US 7973163

    Fused quinoline derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. US 7973045

    Anhydrous form of dasatinib and process for preparation thereof

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. US 7972543

    Process for producing microsphere with use of metal substrate having through-hole

    KURARAY CO., LTD. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. US 7973075

    Kainate receptor-selective epimeric analogs of dysiherbaine

    Northwestern University · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  26. US 7973069

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  27. US 7973169

    Modulators of ATP-Binding Cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  28. US 7973020

    Compositions and methods for inhibiting expression of a gene from the ebola virus

    The United States of America as represented by the Secretary of the Army · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  29. US 7973057

    Thalidomide analogs

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  30. US 7972821

    Production of functional proteins: balance of shear stress and gravity

    The United States of America as represented by the Administrator of the National Aeronautics and Space Administration · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  31. US 7972813

    Tetrodotoxin-resistant sodium channel alpha subunit

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  32. US 7972854

    Methods and compositions for targeted cleavage and recombination

    Sangamo Biosciences, Inc. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  33. US 7972598

    VEGF-binding fusion proteins and therapeutic uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  34. EP 2340815

    Verfahren und Vorrichtung zur Herstellung einer überlappenden Schutzfolie für ein transdermales therapeutisches System

    ACINO AG [DE] · Granted Wed Jul 06 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Tue Jul 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  35. US 7977427

    Method involving 1-benzotriazolyl carbonate esters of polymers

    Nektar Therapeutics · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  36. US 7976834

    Multi-arm polypeptide-poly(ethylene glycol) block copolymers as drug delivery vehicles

    Nektar Therapeutics · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  37. US 7976743

    Gas-containing liposomes

    The Board of Regents of the University of Texas System · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  38. US 7976832

    Active topical skin protectants containing amines, polyalkenimines and /or derivatives

    The United States of America as represented by the Secretary of the Army · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  39. US 7977468

    Chromosome 3p21.3 genes are tumor suppressors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  40. US 7977359

    5-lipdxygenase-activating protein (FLAP) inhibitors

    AMIRA PHARMACEUTICALS, INC. · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  41. US 7977457

    Fusion proteins, uses thereof and processes for producing same

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  42. US 7977322

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  43. US 7977312

    Compositions and methods for increasing bone mineralization

    Darwin Discovery Limited · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  44. US 7976936

    Endoprostheses

    UNIVERSITY OF CONNECTICUT · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  45. US 7976853

    Process for producing coated preparation

    Takeda Pharmaceutical Company Limited · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  46. US 7976851

    Non-toxic biofilm inhibitor

    The Regents of the University of Colorado, a Body Corporate · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  47. US 7976868

    Liposomes comprising duramycin and anti-viral agents

    The Board of Regents of the University of Texas System · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  48. US 7977320

    Method of increasing efficacy of tumor cell killing using combinations of anti-neoplastic agents

    The Regents of the University of California · Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many pharma patents expire in 2031?

902 published patents in our USPTO index have expiration dates falling in calendar year 2031.